| MeSH term | MeSH ID | Detail |
|---|---|---|
| Down Syndrome | D004314 | 18 associated lipids |
| Pregnancy Complications | D011248 | 19 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Cerebrovascular Disorders | D002561 | 25 associated lipids |
| Ascites | D001201 | 25 associated lipids |
| Endometriosis | D004715 | 29 associated lipids |
| Coronary Artery Disease | D003324 | 47 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
2,3-dinor, 6-keto-PGF1alpha
2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 782 references associated with 2,3-dinor, 6-keto-PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 2,3-dinor, 6-keto-PGF1alpha
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
NCBI Entrez Crosslinks
All references with 2,3-dinor, 6-keto-PGF1alpha
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Tsikas D et al. | Solid- and liquid-phase extraction for the gas chromatographic-tandem mass spectrometric quantification of 2,3-dinor-thromboxane B2 and 2,3-dinor-6-oxo-prostaglandin F1 alpha in human urine. | 2000 | J Chromatogr A | pmid:10941682 |
| Arnaud J et al. | Effect of low dose antioxidant vitamin and trace element supplementation on the urinary concentrations of thromboxane and prostacyclin metabolites. | 2007 | J Am Coll Nutr | pmid:17914127 |
| Martineau A et al. | Defective synthesis of vasodilator prostaglandins in the spontaneously hypertensive rat. | 1984 Mar-Apr | Hypertension | pmid:6373595 |
| Falardeau P and Martineau A | In vivo production of prostaglandin I2 in Dahl salt-sensitive and salt-resistant rats. | 1983 Sep-Oct | Hypertension | pmid:6352480 |
| Minuz P et al. | Altered excretion of prostaglandin and thromboxane metabolites in pregnancy-induced hypertension. | 1988 | Hypertension | pmid:3290103 |
| Guarner F et al. | Increased synthesis of systemic prostacyclin in cirrhotic patients. | 1986 | Gastroenterology | pmid:3510938 |
| Guarner C et al. | Systemic prostacyclin in cirrhotic patients. Relationship with portal hypertension and changes after intestinal decontamination. | 1992 | Gastroenterology | pmid:1727763 |
| Watson ML et al. | Systemic synthesis of prostaglandin I2 following sustained infusion of angiotensin II in conscious dogs. | 1986 | Eur. J. Pharmacol. | pmid:3530786 |
| Greer IA et al. | Synergistic inhibitory effects of adrenoceptor antagonists and prostacyclin, and umbilical artery-derived prostacyclin-like activity on platelet aggregation. | 1990 May-Jun | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:1970789 |
| Vesterqvist O and Gréen K | Effects of naproxen on the in vivo synthesis of thromboxane and prostacyclin in man. | 1989 | Eur. J. Clin. Pharmacol. | pmid:2515064 |
| Vesterqvist O | Rapid recovery of in vivo prostacyclin formation after inhibition by aspirin. Evidence from measurements of the major urinary metabolite of prostacyclin by GC-MS. | 1986 | Eur. J. Clin. Pharmacol. | pmid:3519239 |
| Larsson PT et al. | Metoprolol does not reduce platelet aggregability during sympatho-adrenal stimulation. | 1992 | Eur. J. Clin. Pharmacol. | pmid:1387607 |
| Edlund A et al. | Acipimox stimulates skin blood flow by a cyclo-oxygenase-dependent mechanism. | 1990 | Eur. J. Clin. Pharmacol. | pmid:2125938 |
| Lahoz C et al. | Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure. | 1997 | Eur. J. Clin. Invest. | pmid:9352251 |
| Ross S et al. | Association of cyclooxygenase-2 genetic variant with cardiovascular disease. | 2014 | Eur. Heart J. | pmid:24796340 |
| Closa D et al. | Changes of systemic prostacyclin and thromboxane A2 in sodium taurocholate- and cerulein-induced acute pancreatitis in rats. | 1993 | Dig. Dis. Sci. | pmid:7678383 |
| Koivisto VA et al. | Stimulation of prostacyclin synthesis by physical exercise in type I diabetes. | 1989 | Diabetes Care | pmid:2507264 |
| Rautanen M et al. | Experimental fat embolism induces urine 2,3-dinor-6-ketoprostaglandin F1alpha and 11-dehydrothromboxane B2 excretion in pigs. | 1997 | Crit. Care Med. | pmid:9233750 |
| Watson ML et al. | Prostaglandins and kallikrein during volume expansion in normal man. | 1984 | Contrib Nephrol | pmid:6570094 |
| Förstermann U and Feuerstein TJ | Decreased systemic formation of prostaglandin E and prostacyclin, and unchanged thromboxane formation, in alcoholics during withdrawal as estimated from metabolites in urine. | 1987 | Clin. Sci. | pmid:3308287 |